Leucine-rich repeat kinase 2 (LRRK2) is expressed at higher levels in the immune cells, especially in patients with late-onset PD compared to age-matched controls, which may regulate the progression of PD (Cook et al., 2017). The gene discussed is LRRK2; the disease is Parkinson disease.